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Abstract 
The influence of metal debris exposure on the subsequent immune response and resulting soft 
tissue injury following metal on metal (MoM) hip arthroplasty is poorly understood. Some reports 
have suggested that debris generated from the head neck taper junction is more destructive than 
equivalent doses from metal bearing surfaces. We investigated the influence of the source and 
volume of metal debris on Cr and Co concentrations in corresponding blood and hip synovial fluid 
samples and the observed agglomerated particle sizes in excised tissues using regression analysis of 
prospectively collected data. A total of 199 explanted MoM hips were analysed to determine rates of 
volumetric wear at the bearing surfaces and taper junctions. Multiple regression statistical modelling 
suggested that a greater source contribution of metal debris from the taper junction was associated 
with smaller aggregated particle sizes in the local tissues and a relative reduction of Cr ion 
concentrations in the corresponding synovial fluid and blood samples. Metal debris generated from 
taper junctions appears to be of a different morphology, composition and therefore, potentially, 
immunogenicity to that generated from bearing surfaces. This may provide some understanding of 
the increased incidence of soft tissue reactions reported in patients implanted with THRs compared 
to patients with hip resurfacings.  
 
 
Introduction 
The host immune response to particles generated by orthopaedic devices is largely determined by 
the composition, morphology and volume of the debris.1 Cobalt chrome (CoCr) metal on metal 
(MoM) hip prostheses in general wear at much lower rates than metal on polyethylene (MoP) 
devices and the particles released into the body are smaller. For this reason, MoM hips were 
reintroduced in an attempt to reduce the incidence of component loosening secondary to 
macrophage mediated osteolysis seen in association with polyethylene debris.2 
Unfortunately it is now recognised that metal debris, specifically chromium (Cr) and cobalt (Co) in 
ionic or particulate form, is linked to a spectrum of macroscopic pathologies which have been 
grouped under the umbrella term “adverse reactions to metal debris” (ARMD).3 
We have previously published our experience with a cohort of patients implanted with ASR (Articular 
Surface Replacement (Depuy, Indiana)) resurfacing and ASR total hip replacements (THRs).3 These 
devices utilise identical bearing surfaces (the surfaces of the head and cup) in terms of materials and 
sizes but with the THR there is an extra metallic interface: the head-neck taper junction. We found 
that, compared to the ASR resurfacing patients, the ASR THR patients experienced double the failure 
rate of their devices secondary to ARMD. We also found that those reactions tended to be of greater 
severity in terms of the extent of tissue necrosis. Paradoxically, the THR patients had been exposed 
to, on average one third the total volume of CoCr debris as the resurfacing patients.3 
We therefore hypothesised that debris released from taper junctions of MoM THRs is different to 
bearing debris in terms of size and composition, with taper debris more representative of the base 
alloy. We examined this hypothesis by comparing tissue samples and blood and joint synovial fluid 
Co and Cr concentrations in patients with MoM THRs (with a taper junction formed of a male 
titanium alloy taper with a female CoCr surface) with patients implanted with MoM resurfacings (no 
taper).  
  
Methods 
We have been conducting a prospective investigation of the failure of MoM hip prostheses since 
2008. Patients who experience failure of these devices at our centre routinely undergo pre-revision 
blood and hip joint synovial fluid Co and Cr metal ion measurement. Tissue samples excised at 
revision surgery from multiple sites surrounding the prosthesis are analysed by a pathologist with 
extensive experience in MoM cellular responses using published methodology.4 Explanted 
prostheses undergo analysis of the bearing and female taper surfaces to determine the amount of 
material loss, in volumetric terms, which has occurred in vivo.3 
Given that seven variables in total were being investigated (see table 1), a number of which were 
categorical and potentially the subject of bias, we believed that we would need over 80 complete 
data sets in each of the resurfacing and THR groups to derive meaningful results. Approximately 40 
to 50 complete data sets were received per year of the study, therefore a four-year cut off was 
agreed upon. The study obtained ethical approval from Durham and Tees Valley 2 local research 
ethics committee and was sponsored by Newcastle Upon Tyne Hospitals Trust. Only contemporary 
MoM prostheses were included, meaning that all metal components were manufactured from the 
same medical grade high carbon content with the same base CoCrMo medical grade alloy. There 
were however differences in the manufacturing processes, which are described in table 2. 
Wear Analysis. Explanted prostheses were analysed using a coordinate measuring machine (Legex 
322; Mitutoyo, Halifax, United Kingdom). Wear analysis involves the calculation of the total amount 
of material that has been removed from the components in vivo. This material loss can be expressed 
in volumetric terms either as “total volumetric wear (in mm3)” or this total value can be divided by 
the number of years in vivo to provide a mean “volumetric wear rate” (expressed in mm3/year). The 
accuracy of such methods has been validated and is of the order of 0.5mm3 per component for 
bearings and 0.2mm3 for tapers.5 Throughout this paper, wear rates refer only to volumetric CoCr 
material loss. For resurfacings, “total volumetric wear rates” refer to the bearing surface wear rates 
(combined head and cup volumetric wear rates). For THRs, “total volumetric wear rates” refer to the 
combined wear rates of the head, the cup and the female taper surface.   
Assessment of metal particle load in tissues. Previous authors have concluded that average particle 
sizes released from MoM hips range from about 30 to 100 nm.6 To our knowledge however it is 
unclear whether it is the size and morphology of particles in solution, or the particles which 
aggregate and are deposited in local tissues, which are the determinants of the subsequent immune 
response. As the primary purpose of this paper was to establish relative differences in the 
periprosthetic environment related to variations in wear rates and the source of wear, we believed it 
was legitimate for this study to report the size of precipitated, aggregated particles as graded under 
light microscope examination. This was assessed by the method used to assess tissue iron overload 
in liver biopsies (see table 3).7  We have described these approaches in detail in an earlier paper 
which focused on the cellular response involved in the ARMD spectrum.4  
Joint fluid Co and Cr concentrations. Prior to revision surgery, joint fluid was extracted under local 
anaesthetic in order to rule out infection and to analyse the Co and Cr concentrations using the 
same technique and equipment as previously described in the collection of blood specimens.3 
Samples did not undergo acid digestion prior to analysis.  
Macroscopic revision findings. The amount of fluid observed at revision was categorised as described 
in our previous publication: 0 - no abnormal fluid; 1 - small amount of abnormal fluid; 2 - copious 
amounts of abnormal fluid; 3 - fluid under pressure/fistulation of fluid. 
Statistical analysis. Initially, the distribution of blood and joint Co and Cr concentrations, as well as 
volumetric wear rates from the bearing and taper surface were examined using the Shapiro-Wilk 
test. All values were determined to be non-parametrically distributed (p<0.001 for all tests) and 
were therefore log normalised. A number of multiple regression models (including stepwise and 
hierarchical approaches) were constructed in order to investigate whether any differences in the 
outcome variables were brought about due to differences in the source of the metal debris (table 1). 
As can be seen in figure 1, taper debris, generated from a smaller surface interface than that of the 
bearing surfaces, was generally of lower magnitude. To account for this, the proportion of the total 
volumetric wear rate that was contributed by the taper surface was calculated. For example, if the 
total wear rate was 10mm3/year and the taper wear rate was 1mm3/year then the value entered 
into the regression model was 0.1. Statistical analysis was carried out using Minitab v17 (Coventry, 
UK). There is limited evidence on this subject but we believed it reasonable to include patient age 
and sex for all analyses (metal ions are excreted renally; renal function may decline with age8 and 
some authors have noted a link between patient sex and ion concentrations.9) The observed particle 
grade in retrieved tissues was also included, as the surface area of agglomerated particles may affect 
rate of ionic release secondary to corrosion.10 For the joint fluid analysis, fluid grade was included as 
a variable in order to rule in or out effects secondary to dilution.  
 
Results 
A total of 199 hips (116 THRs and 83 hip resurfacings) were analysed which had corresponding 
blood, joint and tissue samples. Patient demographics, clinical parameters and implant details, are 
shown in table 4. 
Note: The various multiple regression modelling approaches returned consistent findings. The 
models reported are those that best described the response variables where all the coefficients of 
the explanatory variables were significantly different from zero with significance drawn at p < 0.05. 
Beta standardised coefficients are reported as “β” with standard error as “SE”. 
Part 1: Is taper debris associated with different agglomerated particle sizes in retrieved tissues 
compared to bearing surface wear?  
In the ordinal logistic regression model, total wear rate appeared to have the strongest influence on 
agglomerated particle size (β = 0.339, SE = 0.071 p<0.001), with greater wear rates being associated 
with larger observed particle sizes. There was a trend towards smaller observed particle sizes when a 
greater proportion of the total volume of wear was contributed by the taper (β =-0.194, SE = 0.074, 
p = 0.014). These two variables accounted for approximately 21% of the overall variation. Patient 
sex, age, device type and fluid grade were not found to be significant factors. As can be seen in 
figure 2, smaller particle grades were associated with larger Co:Cr ratios in the corresponding joint 
fluid samples. In other words, smaller agglomerates of particles were more likely to be associated 
with Co rich joint fluids. 
Part 2: Is taper debris associated with different metal ion concentrations in the joint fluid compared 
to bearing surface wear?  
Joint fluid Cr. In the best fitting regression model, total wear rate was the dominant variable (β = 
0.716, SE = 0.05, p < 0.001). A greater proportion of wear contributed by the taper was associated 
with a significantly lower joint Cr concentration (β = -0.107, SE = 0.050, p = 0.03), as was male sex (β 
= -0.150, SE = 0.047, p = 0.002). These two variables however added relatively little to the R2 value 
derived from total wear rate on its own (R2=58% versus R2=55%). Fluid grade, device type, 
agglomerated particle size grade and patient age were not found to be significant.  
Joint fluid Co. In the best fitting regression model, a greater proportion of taper wear was not 
associated with a significantly higher Co concentration. Total volumetric wear rate (β = 0.703, SE = 
0.060, p < 0.001), fluid grade (β = 0.112, SE = 0.04, p = 0.05) and female sex (β=0.114, SE = 0.055, p = 
0.040) were the only variables significantly associated with greater Co concentrations.  
 
Part 3: Is taper debris associated with different metal ion concentrations in the blood compared to 
bearing surface wear?  (unilateral patients only) 
Blood Cr.  A greater proportion of taper wear was associated with a lower blood Cr concentration (β 
= -0.128, SE = 0.037, p = 0.003). As with the joint fluid model, the dominant variable to explain blood 
Cr concentrations was clearly total volumetric wear rate (β = 0.874, SE = 0.041, p < 0.001). Female 
sex was associated with greater Cr concentrations (β = 0.095, SE = 0.037, p = 0.045), as was fluid 
grade (β = 0.082, SE = 0.038, p = 0.031).  The presence of the ASR resurfacing device was associated 
with lower Cr concentrations (β = -0.148, SE = 0.037, p < 0.001). However, the proportion of taper 
wear, female sex and the presence of the ASR resurfacing device added relatively little to the R2 
value derived from total wear rate on its own (R2=80% versus R2=76%). Particle size and patient age 
had no significant effect. 
It was observed that as total wear rates increased, the ratio between the joint fluid Cr 
concentrations and the equivalent Cr concentrations in blood samples also increased. This implied 
that Cr was retained in the joint. To investigate this a further regression analysis was performed on 
joint Cr:blood Cr ratio versus combined wear rates and particle sizes. The equation for this model 
was as follows: JointCr:bloodCr=1.58+0.06*particle grade+0.57*logtotalwearrate(R2=24%,p<0.001). 
This confirmed that as wear rates increased, joint Cr concentrations became proportionately larger 
than the blood Cr concentration. This effect was not seen with Co (figure 3).  
Blood Co. A greater proportion of taper wear was not significantly associated with a higher blood Co 
concentration. Only total volumetric wear rate (β = 0.927, SE = 0.039, p < 0.001), the ASR resurfacing 
device (β = -0.162, SE = 0.042, p < 0.001) and fluid grade (β = 0.130, SE = 0.036, p < 0.001) were 
found to be significant variables. Again, the full best fitting regression model provided only a 
marginal increase in the power of the model to explain the variation in blood Co compared to total 
volumetric wear rate on its own (R2=82% versus R2=78%).  
 
Having established that particle size and joint fluid grade had minimal impact on measured blood Cr 
and Co concentrations, we then drew from a larger database of results from the Northern Retrieval 
Registryi, which conducts wear analysis on explants retrieved from external hospital trusts across the 
United Kingdom. These datasets do not typically include joint fluid/particle observations but the 
advantage of this further analysis was to allow us to select only unilateral Pinnacle devices thereby 
eliminating the potential confounding effect of wrought versus as cast CoCr components (table 2). 
This left us with 107 explanted 36mm diameter Pinnacle wear results with corresponding blood Cr 
and Co results from patients whose sex and age were known (see table 5). Regression models which 
were constructed using this patient data set alone confirmed the results reported above. For blood 
Cr, the best fit model (R2=70%) showed that the dominant variable was once again total volumetric 
wear (β = 0.719, SE = 0.057, p <0.001) and that the proportion of wear volume contributed by the 
taper was inversely related to blood Cr (β = -0.269, SE = 0.057, p <0.001). Patient age and sex were 
both non-significant.   
For blood Co, again the total rate of volumetric wear was the most important variable (β = 0.882, 
SE=0.052, p <0.001), again the taper contribution was insignificant (p=0.249) and increasing age was 
associated with greater Co concentrations (0.151, SE = 0.050, p = 0.003). Female sex was found to be 
insignificant. The overall power of the model was 75% (p<0.001).  
 
Discussion 
We conducted this study in order to investigate our suspicion that taper junction debris may be of a 
different composition to that generated by the bearing surfaces of MoM hips. The main limitation of 
this study was the use of surrogate measures to gauge the composition and morphology of released 
debris. We believe we are justified in reporting the surrogate measures of the composition of debris 
(ie precipitated, agglomerated particulate sizes in retrieved tissue and blood/joint metal ion 
concentrations) however as these surrogate measures are important clinical outcomes in 
themselves.  
 
The main findings of this investigation were as follows: 
1. As the proportion of wear debris contributed by the taper increased, there was a relative 
reduction in Cr concentrations in the corresponding blood and joint fluid samples. This implies that 
taper debris is composed of less Cr relative to bearing surface debris. 
2. Agglomerated particulate sizes in tissue samples tended to increase with increases in total wear 
rates, though tended to be smaller when there was a greater source contribution from the taper. 
This implies that taper debris may be of a different morphology to bearing surface debris.  
3. As bearing surface wear rates increased, joint fluid Cr concentrations rose disproportionately to 
blood Cr concentrations, implying the accumulation of Cr in the periprosthetic environment with 
high rates of wear. 
4. Patient sex, age and the presence of joint fluid effusions appear to interact affect the body’s 
handling of Cr and Co debris.  
  
 
Metal on Metal Bearing Surface Wear 
The clinical usefulness of medical grade CoCr alloy is due to its hardwearing nature and its resistance 
to the corrosive effects of the human body. These key properties depend on the alloy’s ability to 
spontaneously generate a Cr oxide passive layer in vivo.10 In MoM hips, when the femoral head 
contacts against the cup during activities of daily living, this passive layer is rubbed off to some 
extent but, in a well-functioning prosthesis, is thought to be rapidly regenerated.10 Wear rates of 
MoM joints can in some circumstances be extremely low – as low as reported in the idealised 
environment of a hip simulator study.11 Hip simulator studies have shown that the debris generated 
in such low wearing environments is primarily Cr particulate debris, with only a minority of particles 
containing Co.12 Consistent with these findings, numerous blood metal ion studies have shown 
extremely low blood Co concentrations in patients with well-functioning MoM prostheses9, indicates 
that Co release, in ideal situations, is very limited. This was clearly not the case in the majority of the 
patients in the current study, as evidenced by the gross elevations in blood and joint fluid Co 
concentrations.  
 
In the current study, as wear rates increased, Co concentrations became larger than the equivalent 
Cr concentrations in the blood (figure 3).  The reverse was true in the joint fluid, where Cr 
concentrations, in general, became larger than Co as bearing wear increased. Concomitantly, the 
ratio of joint fluid Cr to blood Cr concentration became larger. Furthermore, as bearing surface wear 
rates increased, agglomerated particulate sizes in the tissues tended to increase. This observation 
was consistent with previous simulator studies13 which showed an increase in particle size as wear 
rates increased. Taken in combination, these findings imply that larger particles precipitate, become 
trapped and slowly corrode, producing massive local concentrations of Cr ions in the joint fluid. Co, 
more soluble, more easily diffuses into the blood stream. The strongest evidence of this effect is the 
relative clearance rate of the two elements following removal of MoM prostheses.14  
 
Davda et al15 proposed that joint fluids must undergo acid digestion to adequately assess the metal 
content. While we agree acid digestion may be useful, we believe it is just as useful to gauge the 
actual periprosthetic exposure to ionic debris with the fluid in its original form. None of the 
conclusions in this paper would have changed if Davda et al’s suggestions had been followed – 
simply that we are likely to have under measured the total concentration of Cr in the hip fluids 
experiencing very high rates of wear. 
 
 
Taper Wear 
The taper junction, which, in this study featured connections composed of a CoCr head press fit onto 
a titanium stem, has a smaller surface area and thus material release is generally lower in total 
volumetric terms.16 We have previously shown that the CoCr surface in these type of tapers is unable 
to sustain a Cr oxide layer of sufficient thickness, leaving the underlying bulk alloy vulnerable to 
wear.17 Bulk CoCr alloy is composed of material with an approximate Co to Cr ratio of 2.1: 1 by 
weight.10 It is likely the absence of this thick oxide layer which leads to the generation of particulate 
debris which is more representative of the composition of the bulk alloy.  Some authors have 
suggested that elevated Co to Cr in the bloodstream is diagnostic of taper failure and due to 
preferential leaching of Co secondary to corrosion.18 But the apparent disproportionate release of Co 
beyond that present in the alloy appears to be illusory. The observed clinical effect is equally, if not 
to a greater extent, due to a reduction in Cr release from the taper junction (for reasons described 
above) rather than an increase in Co release secondary to a corrosive mechanism specific to the 
taper.  
 
Can blood metal ion screening be used to detect taper failure? Using total volumetric loss from the 
taper of 1mm3 – which in our experience is of unquestionable clinical significance5 – to diagnose 
taper failure, the resulting diagnostic accuracy of blood Co:Cr ratio was investigated using receiver 
operating curves (figure 4). This confirmed our suspicion that while high Co:Cr ratios are indeed 
indicative of a failing taper, this parameter has extremely poor sensitivity. This is clearly due to the 
fact that the bearing surfaces, aside from providing the bulk of the metal, also  tend to generate 
variable ratios of Co:Cr (as well as agglomerated particle sizes) in both the joint fluid and the blood 
stream. 
 
The results reported in this paper are of clinical importance not just in the assessment of patients 
with MoM prostheses, but particularly for those with CoCr femoral heads used as part of MoP 
systems. With MoP prostheses the relative contribution of CoCr from the bearing interface is far 
lower, meaning that interpretation of blood and joint Co and Cr concentrations will be of much 
greater significance in locating the source of debris.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
References 
1. Goodman SB. Wear particles, periprosthetic osteolysis and the immune system. Biomaterials. 
2007;28(34):5044-8.  
2. Cooper RA, McAllister CM et al. Polyethylene debris-induced osteolysis and loosening in 
uncemented total hip arthroplasty. A cause of late failure. J Arthroplasty. 1992;7(3):285-90.  
3. Langton DJ, Jameson SS, Joyce TJ et al. Accelerating failure rate of the ASR total hip replacement. J 
Bone Joint Surg Br. 2011;93(8):1011-6.  
4. Natu S, Sidaginamale RP, Gandhi J et al. Adverse reactions to metal debris: histopathological 
features of periprosthetic soft tissue reactions seen in association with failed metal on metal hip 
arthroplasties. J Clin Pathol. 2012;65(5):409-18.  
5. Langton DJ, Sidaginamale RP, Lord JK et al. Taper junction failure in large-diameter metal-on-metal 
bearings. Bone Joint Res 2012;1:56–63. 
6. Catelas I, Bobyn JD, Medley JJ et al. Effects of digestion protocols on the isolation and 
characterization of metal-metal wear particles. II. Analysis of ion release and particle composition. J 
Biomed Mater Res. 2001;55(3):330-7. PubMed PMID: 11255186. 
7. Searle J, et al. "Iron storage disease." Pathology of the liver, 3rd edn. Edinburgh: Churchill 
Livingstone (1994): 219-41. 
8. Lindeman RD, Tobin J, Shock NW. Longitudinal studies on the rate of decline in renal function with 
age. Journal of the American Geriatrics Society. 1985;33:278-285. 
9. Vendittoli PA, Mottard S, Roy AG et al. Chromium and cobalt ion release following the Durom high 
carbon content, forged metal-on-metal surface replacement of the hip.J Bone Joint Surg Br. 2007 
Apr;89(4):441-8. 
10. Madl AK, Liong M, Kovochich M et al. Toxicology of wear particles of cobalt-chromium alloy 
metal-on-metal hip implants Part I: Physicochemical properties in patient and simulator studies. 
Nanomedicine. 2015.  
11. Sieber HP, Rieker CB, Kottig P. Analysis of 118 second-generation metal-on-metal retrieved hip 
implants. J Bone Joint Surg Br. 1999;81(1):46-50.  
12. Catelas I, Bobyn JD, Medley JB et al. Size, shape, and composition of wear particles from metal-
metal hip simulator testing: effects of alloy and number of loading cycles. J Biomed Mater Res A. 
2003;67(1):312-27. 
13. Bowsher JG, Hussain A, Williams PA et al. Metal-on-metal hip simulator study of increased wear 
particle surface area due to 'severe' patient activity. Proc Inst Mech Eng H. 2006 Feb;220(2):279-87 
14. Durrani SK, Noble PC, Sampson B et al. Changes in blood ion levels after removal of metal-on-
metal hip replacements: 16 patients followed for 0-12 months. Acta Orthop. 2014;85(3):259-65. 
15. Davda K, Lali FV, Sampson B et al. An analysis of metal ion levels in the joint fluid of symptomatic 
patients with metal-on-metal hip replacements. J Bone Joint Surg Br. 2011 Jun;93(6):738-45. doi: 
10.1302/0301-620X.93B6.25804. 
16. Matthies AK, Racasan R, Bills P, et al. Material loss at the taper junction of retrieved large head 
metal-on-metal total hip replacements. J Orthop Res. 2013;31(11):1677-85. 
17. Moharrami N, Langton DJ, Sayginer O, Bull SJ. Why does titanium alloy wear cobalt chrome alloy 
despite lower bulk hardness: A nanoindentation study? Thin Solid Films 2013;549:79–86. 
18. Kwon YM, Lombardi AV, Jacobs JJ et al. Risk stratification algorithm for management of patients 
with metal-on-metal hip arthroplasty: consensus statement of the American Association of Hip and 
Knee Surgeons, the American Academy of Orthopaedic Surgeons, and the Hip Society. J Bone Joint 
Surg Am. 2014 Jan 1;96(1). 
                                                          
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                                                                                                    
 
 
Table 1. Details of the full regression models used to examine variable interaction in the three parts 
of the study. “*” denotes linear regression and “Ɨ” ordinal logistic regression.  
 
Part 1: Particle size in retrieved tissues – all patients 
 
Predictors Dependent variables 
 
Total volumetric wear rate 
Proportion of wear contributed by taper  
Fluid grade 
Age 
Sex 
Device type 
 
 
 
 
Agglomerated particle size gradeƗ   
 
Part 2: Joint Co and Cr concentrations – all patients 
 
 
 
Total volumetric wear rate 
Proportion of wear contributed by taper 
Fluid grade 
Age 
Sex 
Agglomerated particle size grade 
Device type 
 
 
 
 
 
 
Joint fluid Cr and Co concentrations*  
 
 
Part 3: Blood Co and Cr concentrations – only unilateral patients included 
 
 
 
Total volumetric wear rate 
Proportion of wear contributed by taper 
Fluid grade 
Age 
Sex 
Agglomerated particle size grade 
Device type 
 
 
 
 
 
Blood Cr and Co concentrations*  
 
 
 
 
 
 
 
                                                                                                                                                                                    
 
 
Table 2: Manufacturing and composition of the components in the study. ASTM F-75 and ASTM 
F1537 are similar alloys, with compositions by weight F-1537: Cr 26 – 30%; Mo 5 – 7%; Co balance 
and for F-75: Cr 27 – 30%; Mo – 5-7%; Co balance.  
Component CoCrMo alloy As-cast versus wrought 
ASR bearing surfaces ASTM F75 As-cast 
ASR taper sleeve ASTM F799 Wrought 
BHR bearing surfaces ASTM F75 As-cast 
BHR taper ASTM F1357 Wrought 
Pinnacle bearing surfaces ASTM F1537 Wrought 
Pinnacle taper ASTM F1537 Wrought 
 
 
 
Table 3: Aggregated metal particle size assessment. 
Metal particle 
load grade within 
the 
macrophages 
Ease of observation and magnification 
(eyepiece x objective lens) 
Approximate size range 
(microns) 
0 
Granules absent or barely discernable x 
400 
< 0.5  
1 
Barely discernable x250, easily 
confirmed x400 
0.5 – 1  
2 Discrete granules resolved x100 1 – 2  
3 Discrete granules resolved x25 10 – 20  
4 Masses visible x10, naked eye > 100  
 
 
 
 
 
 
 
 
 
                                                                                                                                                                                    
 
 
Table 4: Patient and implant details and distributions of measured parameters. 
Patients and implants 
Mated explanted components (n) 199 
Mean age (yrs) (range) 58  (21 - 84) 
Male:female (n) 67:132 
Mean (range) time to revision (mths)  58 (8 - 109) 
Unilateral vs Bilateral 155:44 
                           Device*                                                                         (n, %) 
ASR 68 (34%) 
Pinnacle THR 36mm 75 (38%) 
ASR THR 37 (19%) 
BHR 15 (7%) 
BHR THR 4 (2%) 
                   Reason for revision                                                                    (n, %) 
ARMD 187  (94) 
Loose components 6 (3) 
Infection 2 (1.0) 
Unexplained pain 4 (2.0) 
Median (range)  bearing surface volumetric wear rate 
(mm3/year) : Hip resurfacings 7.35 (0.62 - 95.5) 
Median (range)  bearing surface volumetric wear rate 
(mm3/year) : THRs 2.02 (0.27 – 68.9) 
Median taper wear rate (mm3/year) (range) 0.20 (0.01 - 8.34) 
Median blood Co levels (μg/l) (range) 9.60 (0.70 - 271.0) 
Median blood Cr levels (μg/l) (range) 9.90 (1.50 - 123.2) 
Median joint fluid Co to Cr ratio (μg/l) (range) 0.69 (0.04 - 38.5) 
Median joint fluid Co levels (μg/l) (range) 926 (13.0 - 46433) 
Median joint fluid Cr levels (μg/l) (range) 894.4 (12.5 - 133120) 
Fluid grades 
0=3(1.5%); 
1=41(20.6%);2=53(26.6%); 
3=106(51.3%)  
Particle sizes 
0 = 9 (4.5%); 1 = 60(30.5%); 2=87 
(43.7%); 3 = 28(14.1%); 4 = 15 
(7.5%) 
 
 
 
                                                                                                                                                                                    
 
 
Table 5. Unilateral Pinnacle patient group used in final analysis. 
Patients and implants 
Mated explanted components (n) 107 
Bearing diameter All 36mm 
Mean age (yrs) (range) 65  (29 - 84) 
Male:female (n) 36 : 71 
Mean (range) time to revision (mths)  60 (12 - 130) 
Reason for revision 
ARMD (n) 101 
Loose components (n) 5 
Infection 1 
Wear rates and metal ion concentrations 
Median (range)  total CoCr volumetric wear 
rate (mm3/year) 
2.17 (0.35 – 69.1) 
Median (range)  bearing surface volumetric 
wear rate (mm3/year) 
1.72 (0.19 – 68.9) 
Median taper wear rate (mm3/year) (range) 0.11 (0 – 2.16) 
Median blood Co levels (μg/l) (range) 5.85 (0.68 - 215.4) 
Median blood Cr levels (μg/l) (range) 6.81 (1.08 – 64.4) 
 
 
 
 
